房颤经皮左心耳封堵术后器械相关血栓
该研究回顾性分析法国8中心2012年2月至2017年1月469例接受左心耳封堵的房颤患者,随访平均13±13个月,339例(72.3%)至少一次影像复查。器械相关血栓年发生率为7.2%,高龄和卒中史为预测因素,双联抗血小板和出院时口服抗凝为保护因素,器械血栓与随访期缺血性卒中/短暂性脑缺血发作独立相关。
要点
- 左心耳封堵术后器械相关血栓年发生率7.2%,需重视影像随访。
- 高龄和卒中史增加器械血栓风险,双联抗血小板和口服抗凝具保护作用。
- 器械血栓者随访期缺血性卒中/短暂性脑缺血发作风险显著升高。
核心结论
- 房颤左心耳封堵术后器械相关血栓并不少见,且与随访期缺血性卒中风险升高强相关。
研究设计与样本
- 回顾性分析法国8中心2012年2月至2017年1月接受2种左心耳封堵装置的469例房颤患者。
- 272例使用Watchman装置,197例使用Amplatzer装置,平均随访13±13个月。
主要发现
- 339例(72.3%)患者至少一次左心耳影像复查,器械相关血栓年发生率为7.2%。
- 89例患者记录98起主要不良事件:器械血栓26例、缺血性卒中19例、短暂性脑缺血发作2例、大出血18例、死亡33例。
- 器械血栓预测因素:年龄每增1岁HR 1.07(95%CI 1.01-1.14,p=0.02),卒中史HR 3.68(95%CI 1.17-11.62,p=0.03)。
- 保护因素:双联抗血小板治疗HR 0.10(95%CI 0.01-0.76,p=0.03),出院时口服抗凝HR 0.26(95%CI 0.09-0.77,p=0.02)。
- 随访期缺血性卒中/短暂性脑缺血发作独立预测因素:器械血栓HR 4.39(95%CI 1.05-18.43,p=0.04),血管疾病HR 5.03(95%CI 1.39-18.23,p=0.01)。
临床怎么用
- 左心耳封堵术后应规范影像随访以早期发现器械相关血栓。
- 对高龄、有卒中史患者加强血栓监测,出院抗栓策略需权衡双联抗血小板或口服抗凝。
局限性
- 回顾性研究设计,仅72.3%患者有影像随访,可能存在检测偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Transcatheter left atrial appendage (LAA) occlusion is an alternative strategy for stroke prevention in patients with atrial fibrillation (AF). OBJECTIVES: This study sought to determine the incidence, predictors, and prognosis of thrombus formation on devices in patients with AF who were treated with LAA closure. METHODS: The study retrospectively analyzed data from patients treated with 2 LAA closure devices seen in 8 centers in France from February 2012 to January 2017. RESULTS: A total of 469 consecutive patients with AF underwent LAA closure (272 Watchman devices [Atritech, Boston Scientific, Natick, Massachusetts] and 197 Amplatzer devices [St. Jude Medical, Minneapolis, Minnesota]). Mean follow-up was 13 ± 13 months, during which 339 (72.3%) patients underwent LAA imaging at least once. There were 98 major adverse events (26 thrombi on devices, 19 ischemic strokes, 2 transient ischemic attacks, 18 major hemorrhages, 33 deaths) recorded in 89 patients. The incidence of device-related thrombus in patients with LAA imaging was 7.2% per year. Older age (hazard ratio [HR]: 1.07 per 1-year increase; 95% confidence interval [CI]: 1.01 to 1.14; p = 0.02) and history of stroke (HR: 3.68; 95% CI: 1.17 to 11.62; p = 0.03) were predictors of thrombus formation on the devices, whereas dual antiplatelet therapy (HR: 0.10; 95% CI: 0.01 to 0.76; p = 0.03) and oral anticoagulation at discharge (HR: 0.26; 95% CI: 0.09 to 0.77; p = 0.02) were protective factors. Thrombus on the device (HR: 4.39; 95% CI: 1.05 to 18.43; p = 0.04) and vascular disease (HR: 5.03; 95% CI: 1.39 to 18.23; p = 0.01) were independent predictors of ischemic strokes and transient ischemic attacks during follow-up. CONCLUSIONS: Thrombus formation on the device is not uncommon in patients with AF who are treated by LAA closure. Such events are strongly associated with a higher risk of ischemic stroke during follow-up. (REgistry on Real-Life EXperience With Left Atrial Appendage Occlusion [RELEXAO]; NCT03279406).
引用
- Fauchier L, Cinaud A, Brigadeau F, et al. Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation. J Am Coll Cardiol. 2018. PMID: 29622159. doi:10.1016/j.jacc.2018.01.076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。